Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech’s nasal vaccine

“Based on the safety and immunogenicity data of the phase 1 clinical trial, the company would be given permission for conducting phase 2 clinical trial,” an official said on the condition of anonymity.